Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis

This publication has 40 references indexed in Scilit:

• Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2005
• Outpatient Intensive Chemotherapy for Small Cell Lung Cancer: Five Years Experience of Modified ‘ICE’ Ifosfamide Carboplatin and Etoposide
  Clinical Oncology, 2002
• Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer: A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923
  Journal of Clinical Oncology, 2002
• Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: Long-term outcome
  Transplantation and Cellular Therapy, 2002
• A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer
  Bone Marrow Transplantation, 2000
• Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide
  New England Journal of Medicine, 1999
• Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer
  New England Journal of Medicine, 1993
• The Impact of Dose Intensity of Standard Chemotherapy Regimens in Extensive Stage Small Cell Lung Cancer
  American Journal of Clinical Oncology, 1993
• Patients with Small-Cell Lung Cancer Treated with Combination Chemotherapy with or without Irradiation
  Annals of Internal Medicine, 1985
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958